OSU-2S, a non-phosphorylatable FTY720 derivative recently developed at the Ohio State University [44] has similar cytotoxic activity in MCL cell lines, suggesting that the S1P signaling is not necessary for FTY720-mediated anti-tumor effect. The gene discussed is MBTPS1; the disease is neoplasm.